Dublin, June 11, 2015 (GLOBE NEWSWIRE) -- Research and Markets (http://www.researchandmarkets.com/research/lnxxj6/h1n1_vaccines) has announced the addition of the "H1N1 Vaccines - Global Strategic Business Report" report to their offering.
This report analyzes the worldwide markets for H1N1 Vaccines in US$ Million. The report provides separate comprehensive analytics for the US, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2014 through 2020.
Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs.
The report profiles 33 companies including many key and niche players such as
- Abbott Laboratories (US)
- CPL Biologicals Pvt. Ltd. (India)
- bioCSL (Australia)
- GlaxoSmithKline Plc. (UK)
- MedImmune, LLC. (US)
- Novartis AG (Switzerland)
- Sanofi Pasteur, SA (France)
- Sinovac Biotech Ltd. (China)
- Zydus Cadila (India)
Key Topics Covered:
1. GLOBAL MARKET OVERVIEW
2. GROWTH DRIVERS/RESTRAINTS/ CHALLENGES
3. AN INSIGHT INTO THE GLOBAL VACCINES MARKET
4. H1N1 PANDEMIC - A HISTORICAL PERSPECTIVE
5. H1N1 INFLUENZA - AN OVERVIEW
6. REGULATORY APPROVALS
7. PRODUCT LAUNCHES
8. RECENT INDUSTRY ACTIVITY
9. FOCUS ON SELECT GLOBAL PLAYERS
10. GLOBAL MARKET PERSPECTIVE
Total Companies Profiled: 33 (including Divisions/Subsidiaries 36)
- The United States (13)
- Japan (2)
- Europe (8)
- - France (3)
- - The United Kingdom (2)
- - Rest of Europe (3)
- Asia-Pacific (Excluding Japan) (13)
For more information visit http://www.researchandmarkets.com/research/lnxxj6/h1n1_vaccines